The NHS criteria for screening women under 50 years for breast cancer are alarmingly narrow, resulting in up to 95% of those at higher risk being overlooked, researchers have warned. The current guidelines, set by the National Institute of Health and Care Excellence (NICE), primarily focus on inherited genes, ignoring key lifestyle factors that could also play a significant role. While older women are routinely offered mammograms, those under 50 receive no breast screening unless they have a strong family history of the disease.
A new risk assessment tool has shed light on this issue, identifying eight times as many women in the under-50 age group who developed breast cancer compared to what was previously recognized. The guidance from NICE suggests that GPs should inquire about family history if a woman expresses concern about her risk. However, this recommendation often only applies to women over 35 using oral contraceptives or considering hormone replacement therapy (HRT).
It’s shocking to note that about one in seven women will develop breast cancer in their lifetime, yet only 5-10% of cases are linked to inherited genes. Lifestyle choices, like alcohol consumption and obesity, have been linked to a significantly higher risk, with hormones contributing to a slight increase as well. Just take the case of Natasha Finch, who was diagnosed with aggressive breast cancer at the tender age of 23, despite having no known risk factors. Her experience has turned her into a powerful advocate for breast cancer awareness, urging young women to pay attention to any symptoms they notice. “I’m so glad I went when I did — because if I hadn’t, who knows?” she reflects on her journey.
Breast cancer is a leading cause of death among women under 50 in the UK, with 96% of cases occurring in women over 40 and 25% in those over 75. It’s important to note that men can also develop breast cancer, with around 420 new cases reported each year in the UK. The message is clear: awareness and timely action are crucial.
Natasha’s story is just one among many that highlight the flaws in the current screening process. Changes to the system must be accessible and equitable for all women, taking into account the anxiety that additional referrals might cause. While the screening program aims to balance early cancer detection with the risk of overdiagnosis and unnecessary treatment, the underlying goal is to remain cost-effective without compromising on health outcomes.
All women are strongly encouraged to familiarize themselves with what is normal for their bodies and to consult a doctor if they notice any changes. The conversation around breast cancer screening needs to evolve, and the voices of those affected are essential in driving that change. Are you or someone you know impacted by these issues?
Kaynak: Orijinal Haber